Accès ouvert · CC BY

Single Nucleotide Polymorphism in Deoxyribonuclease I (DNase I, Q222R/rs1053874 A/G) is associated with Systemic Lupus Erythematosus (SLE)

Article scientifique 2022 Sciences de la santé Anglais

Résumé

Abstract Deoxyribonuclease I (DNase I) is a potential endonuclease enzyme implicated in several immune diseases such as SLE. The objective of this study was to investigate the influence of rs1053874 A/G DNase I polymorphism on SLE susceptibility and to study its influence on serum DNase I levels. The genomic DNA for all participants was genotyped utilizing TaqMan™ assay and Serum DNase I levels were determined by enzyme-linked immunosorbent (ELISA) assay. Individuals with the GA, AA, GA + AA genotypes, and A allele of rs1053874 A/G in the DNase I gene had decreased SLE risk. Also, regression analysis revealed that patients with the genotype "GA + AA" and decreased DNase I levels had decreased risk for prediction of SLE activity (P < 0.05). In Conclusion, The DNase I rs1053874 A/G reduced the incidence of SLE in the Egyptian population. Moreover, “GA + AA” in the same SNP is thought to be an independent predictor of the progression of SLE by reducing serum DNase I levels.

Citer ce document

Zedan, M., Mutawi, T. M., Salah, M. T., & Attia, Z. R. (2022). Single Nucleotide Polymorphism in Deoxyribonuclease I (DNase I, Q222R/rs1053874 A/G) is associated with Systemic Lupus Erythematosus (SLE). Research Square. https://doi.org/10.21203/rs.3.rs-1727269/v1

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 06/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 10

Téléchargements (hors robots) : 0

Méthode de comptage